NHS National Framework Agreement for the Supply of Lanadelumab
NHS National Framework Agreement for the supply of Lanadelumab. The framework agreement will commence on 1.1.2020 for a period of 12 months, with options to extend for a further 36 months.
Buyer
NHS England
Value
£4,844,000
Published
7 Jan 2020
Closes
5 Nov 2019
Procurement details
Source
Contracts Finder
Region
London
Procurement method
Open
Category
Goods
Contract starts
1 Jan 2020
Contract ends
31 Dec 2020
CPV classifications
33600000
Pharmaceutical products
Lots
Lot default NHS National Framework Agreement for the Supply of Lanadelumab
£4,844,000
NHS National Framework Agreement for the supply of Lanadelumab. The framework agreement will commence on 1.1.2020 for a period of 12 months, with options to extend for a further 36 months.
Delivery: British Oversea Territories, Channel Islands, Europe, Isle of Man, Rest of the World, United Kingdom
Documents
Unlock document linkOpportunity notice on Contracts Finder
3 Oct 2019
Opportunity notice on Contracts Finder
Tender notice · Web page
n/a
Not provided
n/a
Tender notice · PDF
n/a
Not provided
n/a
Tender notice · Word document
n/a
Not provided
n/a
Tender notice · Word document
n/a
Not provided
n/a
Tender notice · Word document
n/a
Not provided
n/a
Tender notice · Word document
n/a
Not provided
n/a
Tender notice · Word document
n/a
Not provided
n/a
Tender notice · Excel spreadsheet
n/a
Not provided
n/a
Tender notice · Excel spreadsheet
n/a
Not provided
n/a
Tender notice · Excel spreadsheet
n/a
Not provided
n/a
Tender notice · File
n/a
Not provided
n/a
Tender notice · Word document
Contains public sector information licensed under the Open Government Licence v3.0.